Featured Research

from universities, journals, and other organizations

University Of Pittsburgh Researchers Use Botox To Treat Overactive Bladder

Date:
May 27, 2002
Source:
University Of Pittsburgh Medical Center
Summary:
Botulinum toxin A (BTX) injections, commonly known as botox, show promise as a treatment for a variety of lower urinary tract dysfunctions, according to a study presented by University of Pittsburgh researchers at the American Urological Association Centennial Celebration Annual Meeting. Results will be published in abstract 98 in the AUA proceedings.

ORLANDO, May 25 – Botulinum toxin A (BTX) injections, commonly known as botox, show promise as a treatment for a variety of lower urinary tract dysfunctions, according to a study presented by University of Pittsburgh researchers at the American Urological Association Centennial Celebration Annual Meeting. Results will be published in abstract 98 in the AUA proceedings.

“Bladder dysfunction affects a staggering number of people worldwide. The use of botox injections can offer many of these patients a safe, but temporary, solution to this embarrassing problem,” said Michael Chancellor, M.D., professor of urology and gynecology at the University of Pittsburgh School of Medicine.

In the study, 50 patients were injected with BTX into the bladder or urethra. Patients suffered from a variety of voiding dysfunctions, including multiple sclerosis, spinal cord injury, stroke, overactive bladder, and interstitial cystitis (IC). Each experienced involuntary contractions of the bladder muscle, which either caused incontinence typified by either uncontrolled voiding of urine or the inability to completely empty the bladder.

Forty-one of the 50 patients, or 82 percent, reported a decrease or absence of incontinence after the injections. The decrease was seen within seven days of the injection and symptoms were alleviated for approximately six months. None of the patients experienced long-term complications from the treatment such as stress incontinence or urinary retention.

BTX acts by binding to the nerve endings of muscles, blocking the release of the chemical that causes the muscle to contract. When injected into specific muscles, the muscle becomes paralyzed or weakened, but leaves surrounding muscles unaffected, allowing for normal muscle function.

Common urologic conditions like neurogenic detrusor hyperreflexia and overactive bladder are caused by involuntary contractions of the detrusor muscle, which controls the bladder. This new therapy helps alleviate the contractions, restoring normal bladder function.

Over 17 million Americans suffer from overactive bladder, a condition that significantly affects the patient’s quality of life. An estimated 80 percent of these patients do not seek help or treatment for this condition. Overactive bladder is characterized by the following conditions: frequency, urinating more than eight times in a 24 hour period; urgency, the immediate and strong urge to urinate; and urge incontinence, the inability to suppress urgency resulting in the leaking or loss of urine.


Story Source:

The above story is based on materials provided by University Of Pittsburgh Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pittsburgh Medical Center. "University Of Pittsburgh Researchers Use Botox To Treat Overactive Bladder." ScienceDaily. ScienceDaily, 27 May 2002. <www.sciencedaily.com/releases/2002/05/020527081316.htm>.
University Of Pittsburgh Medical Center. (2002, May 27). University Of Pittsburgh Researchers Use Botox To Treat Overactive Bladder. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/2002/05/020527081316.htm
University Of Pittsburgh Medical Center. "University Of Pittsburgh Researchers Use Botox To Treat Overactive Bladder." ScienceDaily. www.sciencedaily.com/releases/2002/05/020527081316.htm (accessed September 1, 2014).

Share This




More Health & Medicine News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
New Drug Could Reduce Cardiovascular Deaths

New Drug Could Reduce Cardiovascular Deaths

Newsy (Aug. 30, 2014) The new drug from Novartis could reduce cardiovascular deaths by 20 percent compared to other similar drugs. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins